BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16339680)

  • 1. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.
    Cappellini MD; Robbiolo L; Bottasso BM; Coppola R; Fiorelli G; Mannucci AP
    Br J Haematol; 2000 Nov; 111(2):467-73. PubMed ID: 11122086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.
    Taher A; Isma'eel H; Mehio G; Bignamini D; Kattamis A; Rachmilewitz EA; Cappellini MD
    Thromb Haemost; 2006 Oct; 96(4):488-91. PubMed ID: 17003927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalassemia and hypercoagulability.
    Taher AT; Otrock ZK; Uthman I; Cappellini MD
    Blood Rev; 2008 Sep; 22(5):283-92. PubMed ID: 18511163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalassemia and the hypercoagulable state.
    Sirachainan N
    Thromb Res; 2013; 132(6):637-41. PubMed ID: 24125597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic risk in thalassemic patients.
    Moratelli S; De Sanctis V; Gemmati D; Serino ML; Mari R; Gamberini MR; Scapoli GL
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():915-21. PubMed ID: 10091165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet counts in thalassemic children before and after splenectomy.
    Hathirat P; Mahaphan W; Chuansumrit A; Pintadit P; Sasanakul W; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():213-5. PubMed ID: 7886578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining thalassemia as a hypercoagulable state.
    Cappellini MD; Motta I; Musallam KM; Taher AT
    Ann N Y Acad Sci; 2010 Aug; 1202():231-6. PubMed ID: 20712798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
    Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
    Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalassemia intermedia and recurrent priapism following splenectomy.
    Macchia P; Massei F; Nardi M; Favre C; Brunori E; Barba V
    Haematologica; 1990; 75(5):486-7. PubMed ID: 2097271
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of pulmonary thromboembolism in thalassemia intermedia: are these patients at risk for thrombotic events?
    Ciceri L; Amato M; Cappellini MD; Fiorelli G
    Ann Ital Med Int; 2000; 15(3):218-20. PubMed ID: 11059063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation and activation in thalassemia major patients in Indonesia.
    Setiabudy R; Wahidiyat PA; Setiawan L
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):346-51. PubMed ID: 18160592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and distribution of asymptomatic brain lesions in patients with β-thalassemia intermedia.
    Karimi M; Haghpanah S; Bagheri MH; Bordbar MR; Pishdad P; Rachmilewitz EA
    Ann Hematol; 2012 Dec; 91(12):1833-8. PubMed ID: 22824997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive postinjury thrombocytosis is associated with thromboembolic complications.
    Kashuk JL; Moore EE; Johnson JL; Biffl WL; Burlew CC; Barnett C; Sauaia A
    Surgery; 2010 Oct; 148(4):667-74; discussion 674-5. PubMed ID: 20719351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).
    Rafsanjani KA; Mafi N; Tafreshi RI
    Pediatr Hematol Oncol; 2011 Sep; 28(6):497-508. PubMed ID: 21728720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
    Panigrahi I; Agarwal S
    Thromb Res; 2007; 120(6):783-9. PubMed ID: 17346783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients.
    Agouti I; Cointe S; Robert S; Judicone C; Loundou A; Driss F; Brisson A; Steschenko D; Rose C; Pondarré C; Bernit E; Badens C; Dignat-George F; Lacroix R; Thuret I
    Br J Haematol; 2015 Nov; 171(4):615-24. PubMed ID: 26205481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.